Indian pharma market resumes growth trend

9 December 2019
indianpharmabig

India's domestic drug market bounced back to growth in November. After clocking just 5.1% expansion in October, India's domestic pharma market registered 14.5% year-on-year growth in November.

A low base coupled with an early festive season helped pharmaceutical sales rise to $1.77 billion in November, with sales of most Indian drug manufacturers outpacing their foreign peers.

Data from market research firm AIOCD-AWACS showed that, in November last year, the domestic market saw 7% growth. In terms of moving annual turnover (MAT), November growth was 9.8%.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical